A randomized placebo controlled trial of an innovative herbal formula in the prevention of atherosclerosis in postmenopausal women with borderline hypercholesterolemia

Complementary Therapies in Medicine

Volumn 22, Issue 3, 2014, Pages 473-480

  Kwok, Timothy ^a   Leung, Ping Chung ^b   Lam, Christopher ^b   Ho, Suzanne ^b   Wong, Chun Kwok ^b   Cheng, King Fai ^b   Chook, Ping ^b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Atherosclerosis; Herbal medicine; Hypercholesterolemia; Postmenopausal women; Prevention

Indexed keywords

HERBACEOUS AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; TRIACYLGLYCEROL;

ADULT; AGED; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HERBAL MEDICINE; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MEDICINAL PLANT; OUTCOME ASSESSMENT; PLANT ROOT; POSTMENOPAUSE; PUERARIAE LOBATA; RANDOMIZED CONTROLLED TRIAL; SALVIA MILTIORRHIZA; SHORT FORM 36; TRIACYLGLYCEROL BLOOD LEVEL; UNSPECIFIED SIDE EFFECT; CHEMISTRY; MIDDLE AGED; PHYTOTHERAPY; PUERARIA;

AGED; ATHEROSCLEROSIS; CAROTID INTIMA-MEDIA THICKNESS; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; MIDDLE AGED; PHYTOTHERAPY; POSTMENOPAUSE; PUERARIA; SALVIA MILTIORRHIZA;

EID: 84901943421     PISSN: 09652299     EISSN: 18736963     Source Type: Journal    
DOI: 10.1016/j.ctim.2014.03.010     Document Type: Article

References (31)

1. Dae Gill Kang, Yong Gab Yun, Jang Hyun Ryoo, Ho Sub Lee Anti-hypertensive effect of water extract of danshen on renovascular hypertension through inhibition of the renin angiotensin system. Am J Chin Med 2002, 30(1):87-93.
2. Tam W.Y., Chook P., Qiao M., Chan L.T., Chan T.Y., Poon Y.K., et al. The efficacy and tolerability of adjunctive alternative herbal medicine (Salvia miltiorrhiza and Pueraria lobata) on vascular function and structure in coronary patients. J Altern Complement Med 2009, 15(April (4)):415-421.
3. Simon A., Gariepy J., Chironi G., Megnien J.L., Levenson J. Intima-media thickness, a new tool for diagnosis and treatment of cardiovascular risk. J Hypertens 2002, 20(2):159-169.
4. Matthews K.A., Kuller L.H., Sutton-Tyrrell K., Chang Y.F. Changes in cardiovascular risk factors during the perimenopause and postmenopause and carotid artery atherosclerosis in healthy women. Stroke 2001, 32(5):1104-1111.
5. Grundy S.M., Cleeman J.I., Merz C.N., Brewer H.B., Clark L.T., Hunninghake D.B., et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004, 110(2):227-239.
6. Wildman R.P., Schott L.L., Brockwell S., Kuller L.H., Sutton-Tyrrell K. A dietary and exercise intervention slows menopause-associated progression of subclinical atherosclerosis as measured by intima-media thickness of the carotid arteries. J Am Coll Cardiol 2004, 44(3):579-585.
7. Schnyder G., Roffi M., Flammer Y. Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study. A randomized controlled trial. JAMA 2002, 288:973-979.
8. Graham I.M., Daly L.E., Refsum H.M. Plasma homocysteine as a risk factor for vascular disease. The European concerted action project. JAMA 1997, 277:1775-1781.
9. Ridker P.M., Hennekens C.H., Roitman-Johnson B. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 1998, 351:88-92.
10. Ji X.Y., Tan B.K., Zhu Y.Z. Salvia miltiorrhhiza and ischemic diseases. Acta Pharmacol Sin 2000, 21:1089-1094.
11. Fan L.L., O'Keefe D.D., Powell W.J. Effect of puerarin on regional myocardial blood flow and cardiac hemodynamics in dogs with acute myocardial ischemia. Yao Xue Xue Bao 1984, 19:801-807.
12. Zheng G., Zhang X., Zheng J. Hypocholesterolemic effect of total isoflavones from Pueraria lobata in ovariectomized rats. Zhong Yao Cai 2002, 25:273-275.
13. Zhang G., Fang S. Antioxidation of Pueraria lobata isoflavones. Zhong Yao Cai 1997, 20:358-360.
14. Lei X.L., Chiou G.C. Studies on cardiovascular actions of Salvia miltiorrhiza. Am J Chin Med 1986, 14:26-32.
15. Jiang R.W., Lau K.M., Lam H.M. A comparative study on aqueous root extracts of Pueraria thomsonii and Pueraria lobata by antioxidant assay and HPLC fingerprint analysis. J Ethnopharmacol 2005, 96:133-138.
16. Liu B., Woo J., Tang N., Ng K., Ip R., Au A. Assessment of total energy expenditure in a Chinese population by a physical activity questionnaire: examination of validity. Int J Food Sci Nutr 2001, 52:269-282.
17. Xia Z., Gu J., Ansley D.M., Xia F., Yu J. Antioxidant therapy with Salvia miltiorrhiza decreases plasma endothelin-1 and thromboxane A2 after cardiopulmonary bypass in patients with congenital heart disease. J Thorac Cardiovasc Surg 2003, 126:1404-1410.
18. Woo K.S., Chook P., Lolin Y.I. Folic acid improves arterial endothelial function in adults with hyperhomocysteinaemia. J Am Coll Cardiol 1999, 34:2002-2006.
19. Woo K.S., Chook P., Yu C.W. Effects of diet and exercise on obesity-related vascular dysfunction in children. Circulation 2004, 109:1981-1986.
20. Celermajer D.S., Sorensen K.E., Gooch V.M. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992, 340:1111-1115.
21. Corretti M.C., Anderson T.J., Benjamin E. Guidelines for the ultrasound assessment of endothelial-dependent flow mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002, 39:257-265.
22. Deanfield J., Donald A., Ferri C. Endothelial function and dysfunction: Part I. Methodological issues for assessment in the different vascular beds: a statement by the working group on endothelial and endothelial factors of the European Society of Hypertension. J Hypertens 2005, 23:7-17.
23. Salonen R., Salonen J.T. Determinants of carotid intima-media thickness: a population-based ultrasonography study in eastern Finnish men. J Intern Med 1991, 299:225-231.
24. Bots M.L., Hoes A.W., Koudstaal P.J. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 1997, 96:1432-1437.
25. Woo K.S., Chook P., Raitakari O.T. Westernization of Chinese adults and increased subclinical atherosclerosis. Atheroscl Thromb Vascul Biol 1999, 19:2487-2493.
26. O'Leary D.H., Polak J.F., Kronmal R.A. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. NEJM 1999, 340:14-22.
27. Simon A., Gariepy J., Chironi G. Intima-media thickness: a new tool for diagnosis and treatment of cardiovascular risk. J Hypertens 2002, 20:159-169.
28. Polak J.F. Carotid intima-media thickness an early marker of cardiovascular diseases. Ultrasound Quart 2009, 25:55-61.
29. Polak J.F., Pencina M.J., Pencina K.M. Carotid-wall intima-media thickness and cardiovascular events. N Engl J Med 2011, 365:213-221.
30. Woo K.S., Yip T.W.C., Chook Ping Cardiovascular protective effects of adjunctive alternative medicine (Salvia miltiorrhiza and Pueraria lobata) in high-risk hypertension. Evidence-Based Complementary and Alternative Medicine 2013, 2013. Article ID 132912, 8 pages.
31. Sieveking D.P., Woo K.S., Fung K.P. Chinese herbs danshen and gegen modulate key early atherogenic events in vitro. Int J Cardiol 2005, 105:40-45.